Skip to main content
Clinical Trials/IRCT20161010030246N4
IRCT20161010030246N4RecruitingPhase 3

Comparison effect of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration in reducing of amphotericin B-induced nephrotoxicity

Shiraz University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to no limit (—)
Sex
All

Inclusion Criteria

  • Age over 15 years
  • Receive amphotericin for at least 7 days
  • No history of kidney disease (including chronic kidney disease) and hemodialysis
  • Signing up the informed consent form

Exclusion Criteria

  • Heart failure class 3 and 4
  • Known liver failure
  • Known acute or chronic kidney disease
  • Alkalosis (pH greater than 7.5 or sodium bicarbonate plasma greater than 30 meq / lit)
  • Symptomatic hypocalcemia, hypokalemia or hypomagnesemia
  • Sensitivity and any adverse effect that occurred after the injection of bicarbonate in the patient.

Investigators

Similar Trials

Comparison effect of intravenous sodium... | Clinical Trial